MA26445A1 - Composes azabicycliques condenses avec un noyau pyridone et compositions pharmaceutiques les contenant. - Google Patents

Composes azabicycliques condenses avec un noyau pyridone et compositions pharmaceutiques les contenant.

Info

Publication number: MA26445A1
Authority: MA; Morocco
Prior art keywords: same; pharmaceutical compositions; compositions containing; azabicyclic compounds; compounds condensed
Prior art date: 1996-10-30

Application number

MA24849A

Other languages

English (en)

Inventor

Thomas O'neill Brian

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-30

Filing date

1997-10-29

Publication date

2004-12-20

1997-10-29 Application filed by Pfizer filed Critical Pfizer

2004-12-20 Publication of MA26445A1 publication Critical patent/MA26445A1/fr

Links

150000001875 compounds Chemical class 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical group OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)

MA24849A 1996-10-30 1997-10-29 Composes azabicycliques condenses avec un noyau pyridone et compositions pharmaceutiques les contenant. MA26445A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US2880496P	1996-10-30	1996-10-30

Publications (1)

Publication Number	Publication Date
MA26445A1 true MA26445A1 (fr)	2004-12-20

Family

ID=21845528

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA24849A MA26445A1 (fr)	1996-10-30	1997-10-29	Composes azabicycliques condenses avec un noyau pyridone et compositions pharmaceutiques les contenant.

Country Status (17)

Country	Link
US (2)	US6235734B1 (fr)
EP (1)	EP0937077B1 (fr)
JP (2)	JP3621707B2 (fr)
AP (1)	AP9701125A0 (fr)
AR (1)	AR008901A1 (fr)
AT (1)	ATE326468T1 (fr)
AU (1)	AU4394897A (fr)
DE (1)	DE69735891T2 (fr)
ES (1)	ES2264169T3 (fr)
GT (1)	GT199700115A (fr)
HR (1)	HRP970567A2 (fr)
ID (1)	ID18741A (fr)
MA (1)	MA26445A1 (fr)
PA (1)	PA8440201A1 (fr)
TN (1)	TNSN97168A1 (fr)
WO (1)	WO1998018798A1 (fr)
ZA (1)	ZA979706B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6717030B2 (en) *	1998-07-06	2004-04-06	The Regents Of The University Of California	Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse
IL137937A0 (en) *	1999-08-27	2001-10-31	Pfizer Prod Inc	A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
US20010036943A1 (en) *	2000-04-07	2001-11-01	Coe Jotham W.	Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
US20020010192A1 (en) *	2000-06-02	2002-01-24	Coe Jotham Wadsworth	Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
US20020016334A1 (en) *	2000-07-31	2002-02-07	Coe Jotham Wadsworth	Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)
DE60228478D1 (de)	2001-11-30	2008-10-02	Pfizer Prod Inc	Aryl-annellierte azapolyzyklische verbindungen
SE0104463D0 (sv) *	2001-12-29	2001-12-29	Carlbiotech Ltd As	Mellanprodukter för syntes af LHRH-antagonister, sätt att framställa dem och sätt för framställning av LHRH-antagonister
US20030162770A1 (en)	2002-02-22	2003-08-28	Davis Bonnie M.	Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
US20040224962A1 (en) *	2003-05-09	2004-11-11	Pfizer Inc	Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
US20040224963A1 (en) *	2003-05-09	2004-11-11	Pfizer Inc	Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
US8030300B2 (en)	2003-06-10	2011-10-04	Georgetown University	Ligands for nicotinic acetylcholine receptors, and methods of making and using them
ES2331245T3 (es)	2003-07-21	2009-12-28	Pfizer Products Inc.	Compuestos azapoliciclicos condensados con heteroarilo que reducen la adiccion a la nicotina.
US20050234024A1 (en) *	2004-04-14	2005-10-20	Clarke David E	Materials and methods for the treatment of ulcerative colitis
US7135933B2 (en) *	2004-09-29	2006-11-14	Intelliserv, Inc.	System for adjusting frequency of electrical output pulses derived from an oscillator
CA2591330A1 (fr) *	2004-12-07	2006-06-15	Pfizer Products Inc.	Derives de 1,2,3,3a,8,8a-hexahydro-2,7a-diaza-cyclopenta[a]inden-7-one se liant a des sites de recepteurs nicotiniques neuronaux specifiques de l'acetylcholine, utiles dans la modulation de la fonction cholinergique et dans le traitement de troubles de dependance
US20060211649A1 (en) *	2005-03-21	2006-09-21	Eric Marchewitz	Use of cytisine for enhancing physical performance
US20070134169A1 (en) *	2005-12-11	2007-06-14	Rabinoff Michael D	Methods for smoking cessation or alcohol cessation or other addiction cessation
WO2007100430A2 (fr) *	2006-01-27	2007-09-07	Yale University	Analogues de cystisine et d'acétylcholine et procédés de traitement des troubles de l'humeur
WO2007115092A2 (fr) *	2006-03-29	2007-10-11	Georgetown University	Dérivés de cytisine substitués en position 10 et leurs procédés d'utilisation
US7404725B2 (en) *	2006-07-03	2008-07-29	Hall David R	Wiper for tool string direct electrical connection
US8061443B2 (en) *	2008-04-24	2011-11-22	Schlumberger Technology Corporation	Downhole sample rate system
WO2011087654A1 (fr)	2009-12-22	2011-07-21	Avon Products, Inc.	Compositions stimulant la paxilline et leurs utilisations cosmétiques
US20110159125A1 (en)	2009-12-29	2011-06-30	Avon Products, Inc.	CGRP Compositions and Uses Thereof
FR2992315B1 (fr) *	2012-06-25	2014-08-08	Pf Medicament	Derives utiles dans le traitement de maladies du systeme nerveux central
WO2014078568A1 (fr)	2012-11-14	2014-05-22	The Johns Hopkins University	Méthodes et compositions pour le traitement de la schizophrénie
CN102952134B (zh) *	2012-12-05	2015-01-07	苏州药明康德检测检验有限责任公司	含二氟甲基的金雀花碱衍生物及制备方法和抗癌作用研究
RU2630958C2 (ru) *	2015-12-29	2017-09-15	федеральное государственное автономное образовательное учреждение высшего образования "Московский физико-технический институт (государственный университет)" (МФТИ)	Новые макроциклические соединения, содержащие природное 3,7-диазабицикло[3.3.1]нонановое ядро и способ их получения
GB201602145D0 (en)	2016-02-05	2016-03-23	Achieve Pharma Uk Ltd	Salt
US11667638B2 (en)	2016-08-19	2023-06-06	The University Of Bristol	4-substitued cytisine analogues
JP7178158B2 (ja)	2017-07-24	2022-11-25	アチーブファーマユーケイリミテッド	シチシン塩、シチシン塩の溶媒和物または水和物、シチシン塩の製造方法、医薬組成物、および治療方法
KR20220074895A (ko) *	2019-09-12	2022-06-03	어치브 라이프 사이언시즈, 인크.	필요로 하는 대상체의 중독 치료 및/또는 예방을 위한 시티신을 포함하는 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59500217A (ja)	1982-02-22	1984-02-16	ベロルススキ−　ナウチノ−　イスレドワ−チエルスキ−　サニタルノ−　ギギエニチエスキ−　インスチツ−ト	抗ニコチン効果を有する製剤およびその製造法
US4835162A (en)	1987-02-12	1989-05-30	Abood Leo G	Agonists and antagonists to nicotine as smoking deterents
US5242916A (en) *	1992-07-07	1993-09-07	R. J. Reynolds Tobacco Company	Method for treatment of neurodegenerative diseases
TW261531B (fr) *	1993-10-28	1995-11-01	Dynagen Inc
JPH11512443A (ja) *	1995-09-22	1999-10-26	ノボノルディスクアクティーゼルスカブ	新規な置換アザ環式またはアザ二環式化合物

1997
- 1997-10-15 ES ES97942166T patent/ES2264169T3/es not_active Expired - Lifetime
- 1997-10-15 WO PCT/IB1997/001282 patent/WO1998018798A1/fr not_active Ceased
- 1997-10-15 US US09/297,109 patent/US6235734B1/en not_active Expired - Fee Related
- 1997-10-15 EP EP97942166A patent/EP0937077B1/fr not_active Expired - Lifetime
- 1997-10-15 AU AU43948/97A patent/AU4394897A/en not_active Abandoned
- 1997-10-15 AT AT97942166T patent/ATE326468T1/de not_active IP Right Cessation
- 1997-10-15 DE DE69735891T patent/DE69735891T2/de not_active Expired - Fee Related
- 1997-10-15 JP JP52022898A patent/JP3621707B2/ja not_active Expired - Fee Related
- 1997-10-23 AP APAP/P/1997/001125A patent/AP9701125A0/en unknown
- 1997-10-24 HR HR60/028,804A patent/HRP970567A2/hr not_active Application Discontinuation
- 1997-10-24 PA PA19978440201A patent/PA8440201A1/es unknown
- 1997-10-27 GT GT199700115A patent/GT199700115A/es unknown
- 1997-10-28 AR ARP970104980A patent/AR008901A1/es unknown
- 1997-10-28 ID IDP973538A patent/ID18741A/id unknown
- 1997-10-29 ZA ZA979706A patent/ZA979706B/xx unknown
- 1997-10-29 MA MA24849A patent/MA26445A1/fr unknown
- 1997-10-29 TN TNTNSN97168A patent/TNSN97168A1/fr unknown
2001
- 2001-02-14 US US09/783,443 patent/US6630467B2/en not_active Expired - Fee Related
2004
- 2004-09-21 JP JP2004273910A patent/JP2005060403A/ja active Pending

Also Published As

Publication number	Publication date
ZA979706B (en)	1999-04-29
DE69735891D1 (de)	2006-06-22
EP0937077B1 (fr)	2006-05-17
JP3621707B2 (ja)	2005-02-16
US20030065173A1 (en)	2003-04-03
ATE326468T1 (de)	2006-06-15
AP9701125A0 (en)	1997-10-31
JP2000505809A (ja)	2000-05-16
ES2264169T3 (es)	2006-12-16
PA8440201A1 (es)	2000-05-24
ID18741A (id)	1998-05-07
DE69735891T2 (de)	2006-12-14
WO1998018798A1 (fr)	1998-05-07
GT199700115A (es)	1999-04-20
AU4394897A (en)	1998-05-22
JP2005060403A (ja)	2005-03-10
HRP970567A2 (en)	1998-10-31
AR008901A1 (es)	2000-02-23
TNSN97168A1 (fr)	2005-03-15
US6630467B2 (en)	2003-10-07
EP0937077A1 (fr)	1999-08-25
US6235734B1 (en)	2001-05-22

Publication	Publication Date	Title
GR3018318T3 (en)	1996-03-31	Pharmaceutical agents.
NO304468B1 (no)	1998-12-21	6-leddede nitrogenholdige heteroaryl-oksazolidinoner, anvendelse av disse samt legemiddel inneholdende forbindelsen
ZA96937B (en)	1997-11-06	Substituted benzisoxazole and benzisothiazole herbicidal agents.
AU112953S (en)	1991-11-28	Barrier or the like
FR2696799B1 (fr)	1995-06-30	Joint tournant a billes homocinetique.
EP0643967A3 (fr)	1996-02-28	Composition pharmaceutique contenant un analgésique opiacé, e.g. morphine, et un laxative, e.g. bisacodyl.
DZ1559A1 (fr)	2002-02-17	Compositions pharmaceutiques.
FI912759L (fi)	1991-12-12	Pyridinylpiperazinderivat.
ES1033012Y (es)	1996-12-01	Coche-silla infantil biplaza.
HUT71741A (en)	1996-01-29	Emulsifierless paint-bindings materials in granulated form.
NO307704B1 (no)	2000-05-15	8-trifluormetylkinolinkarboksylsyre-derivat, medisinsk preparat inneholdende derivatet, samt anvendelse av et medisinsk preparat
FI924344A7 (fi)	1992-09-28	Sytotoksista ainetta ja permeaatiota tehostavia aineita käsittäviä koo stumuksia
ES1033560Y (es)	1997-02-01	Casita armable para juegos infantiles.
ITRM940302A0 (it)	1994-05-16	"fermapalle ad assorbimento".
EP0617287A3 (fr)	1995-07-26	Dosage biospécifique.
EP0679391A3 (fr)	1996-05-15	Formes pharmaceutiques solides avec un revêtement aromatisé.
FI913894A7 (fi)	1992-02-17	N,n',n'-trisubstituerade-5 -bisaminometylen-1,3-dioxan-4,6-dion-inhibitorer av asyl-coa: kolesterolasyltransferas.
DE3872764D1 (de)	1992-08-20	Tinten-zusammensetzungen und deren zubereitung.
Hoffmeier	1990	The Egyptians
IL149607A0 (en)	2002-11-10	Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3 benzazocines and the use thereof as medicaments
FR2712479B1 (fr)	1995-12-22	Meuble modulaire avec postes d'emmaillotement et/ou postes de toilette.
ZA986800B (en)	2000-01-31	Oligo-Thiophenes useful as antimetastatic agents, a preparation thereof and pharmaceutical compositions containing them.
TR199700059A2 (tr)	1997-08-21	Ikame edilmis diarildikarbonasit-diguanidid'leri, bunlarin imal edilmesine mahsus usul, bunlarin ilac ya da diyagnoz maddesi olarak kullanilmalari ve ayrica bunlari ihtiva eden ilaclar.
Klimowski et al.	1992	The Story So Far
Watanabe	1993	Substance